Description

Image
graphic image

Join the Tennessee Department of Health for an educational Project ECHO session exploring the role of genotyping and resistance testing in hepatitis C (HCV) care. Participants will learn how these tools can inform clinical decision-making and support effective, individualized HCV treatment strategies.

Objectives

  • Identify scenarios when HCV genotyping is recommended
  • Determine when resistance testing should be considered
  • Describe how insurance requirements may differ from HCV guidelines

Speaker

Clark Allen, PharmD, CSP 
Regional One Health

For inquiry, contact [email protected]